Lab Information

Dr. Waqqas Afif

Centre for Innovative Medicine
Department of Medicine (McGill)

Research Profile

 Fundamental: 0%
 Clinical: 20%
 Epidemiology: 80%
 Evaluation: 0%
 This email address is being protected from spambots. You need JavaScript enabled to view it.


Inflammatory bowel disease • Crohn's disease • ulcerative colitis • biologic medications • therapeutic drug monitoring

Research Interests

My research focuses on the safety and efficiency of biologic medications in the treatment of IBD. I am interested in the use of therapeutic drug monitoring to optimize the treatment of IBD patients on biologic medications.

Team Members

Name Position
Germain, Pascale Research Assistant
Recinto, Sherlaine Junior Assistant
Meus, Alexandra Research Nurse

Latest Publications

  1. Verdon, C., Vande Casteele, N., Heron, V., Germain, P. & Afif, W. (2021). Comparison of Serum Concentrations of Ustekinumab Obtained by Three Commercial Assays in Patients with Crohn's Disease. Journal of the Canadian Association of Gastroenterology, vol. 4, p. 73-77.
  2. Restellini, S. & Afif, W. (2021). Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel Disease. Journal of clinical medicine, vol. 10.
  3. Benmassaoud, A., Bessissow, T., Wong, P., Fallone, C. A., Barkun, A., Afif, W., Forbes, N., Martel, M., Geraci, O. & Chen, Y.-I. (2021). Novel Negative Pressure Protective Box in Upper Digestive Endoscopy: A Prospective Case Series. The American journal of gastroenterology.
  4. Al Khoury, A., Xiao, Y., Golovics, P. A., Kohen, R., Afif, W., Wild, G., Friedman, G., Galiatsatos, P., Hilzenrat, N., Szilagyi, A., Wyse, J., Cohen, A., Bitton, A., Bessissow, T. & Lakatos, P. L. (2021). Assessing adherence to objective disease monitoring and outcomes with adalimumab in a real-world IBD cohort. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
  5. Khanna, R. & Afif, W. (2021). Ustekinumab for Ulcerative colitis. Gastroenterology, vol. 160, p. 2184-2186.
  6. Al Khoury, A., Singh, K., Kurti, Z., Gonczi, L., Golovics, P., Kohen, R., Afif, W., Wild, G., Bitton, A., Bessissow, T. & Lakatos, P. L. (2020). The Burden of Anemia Remains Significant over Time in Patients with Inflammatory Bowel Diseases at a Tertiary Referral Center. Journal of gastrointestinal and liver diseases : JGLD, vol. 29, p. 555-559.
  7. Hart, L., Chavannes, M., Lakatos, P. L., Afif, W., Bitton, A., Bressler, B. & Bessissow, T. (2020). Do You See What I See? An Assessment of Endoscopic Lesions Recognition and Description by Gastroenterology Trainees and Staff Physicians. Journal of the Canadian Association of Gastroenterology, vol. 3, p. 216-221.
  8. Farid, D., Li, P., Da Costa, D., Afif, W., Szabo, J., Dasgupta, K. & Rahme, E. (2020). Undiagnosed depression, persistent depressive symptoms and seeking mental health care: analysis of immigrant and non-immigrant participants of the Canadian Longitudinal Study of Aging. Epidemiology and psychiatric sciences, vol. 29, p. e158.
  9. Khanna, R., Zhou, G. Y. & Afif, W. (2020). Comparative Efficacy Trials in Inflammatory Bowel Disease. Gastroenterology, vol. 159, p. 1182-1184.
  10. Verdon, C., Reinglas, J., Coulombe, J., Gonczi, L., Bessissow, T., Afif, W., Vutcovici, M., Wild, G., Seidman, E. G., Bitton, A., Brassard, P. & Lakatos, P. L. (2021). No Change in Surgical and Hospitalization Trends Despite Higher Exposure to Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease in the Québec Provincial Database From 1996 to 2015. Inflammatory bowel diseases, vol. 27, p. 655-661.
More on PubMed 

See also

Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile


Latest News


Research groups